Last reviewed · How we verify

Iron supplement D

Tanabe Pharma Corporation · Phase 3 active Small molecule

Iron supplement D replenishes iron stores to treat or prevent iron deficiency anemia.

Iron supplement D replenishes iron stores to treat or prevent iron deficiency anemia. Used for Iron deficiency anemia.

At a glance

Generic nameIron supplement D
SponsorTanabe Pharma Corporation
Drug classIron supplement
ModalitySmall molecule
Therapeutic areaHematology
PhasePhase 3

Mechanism of action

Iron is an essential mineral required for hemoglobin synthesis and oxygen transport in red blood cells. Iron supplement D provides bioavailable iron to restore depleted iron stores and normalize hemoglobin levels in patients with iron deficiency anemia. The specific formulation or delivery mechanism of this particular iron supplement variant is not well-characterized in available literature.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: